|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.87 CNY | +1.19% |
|
+6.13% | -18.32% |
| 05-25 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| 04-24 | Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Mayinglong Pharmaceutical Group Co., LTD.
End-of-day quote Shanghai S.E.| 2026-06-29 | 2026-06-30 | 2026-07-01 | 2026-07-02 | 2026-07-03 | |
|---|---|---|---|---|---|
| Last | CN¥22.27 | CN¥21.62 | CN¥22.24 | CN¥22.60 | CN¥22.87 |
| Volume | 6,254,597 | 4,886,673 | 4,920,490 | 4,969,360 | 4,168,745 |
| Change | +3.34% | -2.92% | +2.87% | +1.62% | +1.19% |
| Opening | CN¥21.58 | CN¥22.11 | CN¥21.58 | CN¥22.24 | CN¥22.85 |
| High | CN¥22.56 | CN¥22.19 | CN¥22.36 | CN¥22.87 | CN¥23.00 |
| Low | CN¥21.22 | CN¥21.51 | CN¥21.22 | CN¥22.18 | CN¥22.58 |
Performance
| 1 day | +1.19% | ||
| 1 week | +6.13% | ||
| Current month | +5.78% | ||
| 1 month | -3.71% | ||
| 3 months | -9.57% | ||
| 6 months | -18.32% | ||
| Current year | -18.32% | ||
| 1 year | -18.09% | ||
| 3 years | -15.70% | ||
| 5 years | -24.17% | ||
| 10 years | +10.97% |
Volumes
marketsDaily volume
4,168,745
Avg. Volume 20 sessions
4,901,817
Avg. Volume 20 sessions CNY
112,104,554.79
Avg. Volume 20 sessions USD
16,558,515.37
Record volume 1
79,868,720
Record volume 2
62,543,416
Record volume 3
49,134,820
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Market Cap (CNY)
9,734,790,448
Market Cap (USD)
1,434,181,011
Net sales (CNY)
3,866,608,230
Net sales (USD)
569,649,252
Number of employees
2,544
Sales / Employee (CNY)
1,519,893
Sales / Employee (USD)
223,919
Free-Float
64.65 %
Free-Float capitalization (CNY)
6,293,759,878
Free-Float capitalization (USD)
927,230,119
Average Daily Capital Traded
1.15%
Indicators
Moving average 5 days
22.32
Moving average 20 days
22.88
Moving average 50 days
24.1
Moving average 100 days
25.14
Price spread / (MMA5)
-2.40%
Price spread / (MMA20)
+0.04%
Price spread / (MMA50)
+5.38%
Price spread / (MMA100)
+9.93%
RSI 9 days
51.8
RSI 14 days
47.76
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | +6.13% | -18.09% | -15.70% | 1.43B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 339B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 301B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 292B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 225B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +2.00% | +4.66% | +26.79% | +50.83% | 370.12B | |
| Weighted average by Cap. | +2.24% | +5.69% | +42.22% | +83.10% |
Historical Quotes: Mayinglong Pharmaceutical Group Co., LTD.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 21.22 |  | 23 |
| 1 month | 21.22 | | 24.3 |
| Current year | 21.22 | | 29.22 |
| 1 year | 21.22 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.34 |
| 10 years | 12.52 | | 33.54 |
Monthly variations
Annual variations
| 2026 | -18.32% | ||
| 2025 | +7.24% | ||
| 2024 | +7.98% | ||
| 2023 | +6.99% | ||
| 2022 | -21.42% | ||
| 2021 | +42.80% | ||
| 2020 | +15.15% | ||
| 2019 | +30.33% | ||
| 2018 | -34.47% | ||
| 2017 | +2.55% | ||
| 2016 | -9.31% | ||
| 2015 | +41.15% | ||
| 2014 | +17.09% | ||
| 2013 | +23.54% | ||
| 2012 | -18.91% | ||
| 2011 | -24.22% | ||
| 2010 | +19.01% | ||
| 2009 | +185.41% | ||
| 2008 | -43.32% | ||
| 2007 | +141.40% | ||
| 2006 | +59.29% | ||
| 2005 | +6.70% | ||
| 2004 | -2.55% |
- Stock Market
- Stocks
- 600993 Stock
- Quotes Mayinglong Pharmaceutical Group Co., LTD.
Select your edition
All financial news and data tailored to specific country editions
